Greenwich LifeSciences GLSI
NASDAQ GLSI
$18.02 -0.36 (-1.96%)
As of: Sep 30, 2026 · 9:40 AM EDT

Greenwich LifeSciences (GLSI) Operating Expenses (2019 - 2026)

Updated

Greenwich LifeSciences (GLSI) recorded Operating Expenses of $5.73 million in Q1 2026, up 106.8% from $2.77 million a year earlier but down 37.6% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Operating Expenses (2019 - 2026) Analysis & Trends

On a TTM basis, Greenwich LifeSciences' Operating Expenses came in at $22.4 million as of Mar 31, 2026, up 25.4% year-over-year; for FY2025, it came in at $19.45 million, up 10.3% from FY2024.

  • Annual Operating Expenses has increased for five straight years, with a five-year compound annual growth rate of 59.8% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $17.64 million in FY2024 (+89.1%), $9.33 million in FY2023 (+16.0%), $8.04 million in FY2022 (+74.9%) and $4.6 million in FY2021 (+146.7%).
  • Quarterly Operating Expenses has ranged from $753,445 in Q2 2021 to $9.71 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Operating Expenses rose in seven of the last eight quarters, with growth averaging 61.6%.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 258.1% in Q2 2021, against a decline of 5.5% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $9.18 million (Q4 2025), $3.73 million (Q3 2025) and $3.77 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Greenwich LifeSciences 272.64 Mn 272.64 Mn - 5.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.73 Mn
Dec 31, 2025 9.18 Mn
Sep 30, 2025 3.73 Mn
Jun 30, 2025 3.77 Mn
Mar 31, 2025 2.77 Mn
Dec 31, 2024 9.71 Mn
Sep 30, 2024 2.73 Mn
Jun 30, 2024 2.66 Mn
Mar 31, 2024 2.54 Mn
Dec 31, 2023 2.84 Mn
Sep 30, 2023 2.50 Mn
Jun 30, 2023 1.75 Mn
Mar 31, 2023 2.24 Mn
Dec 31, 2022 2.89 Mn
Sep 30, 2022 2.38 Mn
Jun 30, 2022 773,307.00
Mar 31, 2022 1.99 Mn
Dec 31, 2021 2.38 Mn
Sep 30, 2021 866,686.00
Jun 30, 2021 753,445.00
API Access

Greenwich LifeSciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=GLSI&period=max&api_key=YOUR_API_KEY